STOCK TITAN

Cencora Inc. Financials

COR
FY2025 annual
Revenue $321.3B +9.3% YoY
Net Income $1.6B +3.0% YoY
EPS (Diluted) $7.96 +5.7% YoY
Free Cash Flow $3.2B +7.0% YoY
Source SEC Filings (10-K/10-Q) Data as of Jun 30, 2026 Currency USD FYE September

Cencora Inc. (COR) reported $321.3B in revenue for fiscal year 2025, up 9.3% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI COR FY2025

High-volume distribution turns razor-thin margins into cash, but the model depends on working-capital speed more than balance-sheet cushion.

Across FY2023-FY2025, revenue rose by $59.2B while free cash flow stayed near $3.0B a year. Even with gross margin improving to 3.6%, operating margin stayed below 1.0%, which means most of the added gross profit was absorbed by running a larger network.

Current assets stayed below current liabilities in every year shown, yet operating cash flow remained above $2.7B even in the weakest year. That pattern points to a business financed heavily by supplier terms and receivable turnover, not by a large liquidity buffer.

Book equity of $1.5B sits underneath $75.1B of liabilities, so the company operates with a thin accounting capital base for its size. That makes ROE and debt-to-equity look more extreme than the day-to-day business model alone would suggest, and puts more analytical weight on cash flow stability than on book-value ratios.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 51 / 100
Financial Health Score 51/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Cencora Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
54

Cencora Inc. has an operating margin of 0.8%, meaning the company retains $1 of operating profit per $100 of revenue. This results in a moderate score of 54/100, indicating healthy but not exceptional operating efficiency. This is up from 0.7% the prior year.

Growth
67

Cencora Inc.'s revenue grew 9.3% year-over-year to $321.3B, a solid pace of expansion. This earns a growth score of 67/100.

Leverage
49

Cencora Inc. has a moderate D/E ratio of 5.00. This balance of debt and equity financing earns a leverage score of 49/100.

Liquidity
15

Cencora Inc.'s current ratio of 0.90 is below the typical benchmark, resulting in a score of 15/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow
32

Cencora Inc. has a free cash flow margin of 1.0%, earning a moderate score of 32/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns
86

Cencora Inc. earns a strong 103.1% return on equity (ROE), meaning it generates $103 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 86/100. This is down from 233.6% the prior year.

Altman Z-Score Safe
4.83

Cencora Inc. scores 4.83, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral
5/9

Cencora Inc. passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed
2.49x

For every $1 of reported earnings, Cencora Inc. generates $2.49 in operating cash flow ($3.9B OCF vs $1.6B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$321.3B
YoY+9.3%
5Y CAGR+11.1%
10Y CAGR+9.0%

Cencora Inc. generated $321.3B in revenue in fiscal year 2025. This represents an increase of 9.3% from the prior year.

EBITDA
$3.7B
YoY+12.6%
10Y CAGR+18.6%

Cencora Inc.'s EBITDA was $3.7B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 12.6% from the prior year.

Net Income
$1.6B
YoY+3.0%

Cencora Inc. reported $1.6B in net income in fiscal year 2025. This represents an increase of 3.0% from the prior year.

EPS (Diluted)
$7.96
YoY+5.7%

Cencora Inc. earned $7.96 per diluted share (EPS) in fiscal year 2025. This represents an increase of 5.7% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$3.2B
YoY+7.0%
5Y CAGR+11.8%
10Y CAGR-1.4%

Cencora Inc. generated $3.2B in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 7.0% from the prior year.

Cash & Debt
$4.4B
YoY+39.1%
5Y CAGR-1.1%
10Y CAGR+7.2%

Cencora Inc. held $4.4B in cash against $7.5B in long-term debt as of fiscal year 2025.

Dividends Per Share
$2.20
YoY+7.8%
5Y CAGR+5.8%
10Y CAGR+6.6%

Cencora Inc. paid $2.20 per share in dividends in fiscal year 2025. This represents an increase of 7.8% from the prior year.

Shares Outstanding
194M
YoY+0.4%
5Y CAGR-1.0%
10Y CAGR-0.6%

Cencora Inc. had 194M shares outstanding in fiscal year 2025. This represents an increase of 0.4% from the prior year.

Margins & Returns

Gross Margin
3.6%
YoY+0.2pp
5Y CAGR+0.8pp
10Y CAGR+1.0pp

Cencora Inc.'s gross margin was 3.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.2 percentage points from the prior year.

Operating Margin
0.8%
YoY+0.1pp
5Y CAGR+3.5pp
10Y CAGR+0.5pp

Cencora Inc.'s operating margin was 0.8% in fiscal year 2025, reflecting core business profitability. This is up 0.1 percentage points from the prior year.

Net Margin
0.5%
YoY0.0pp
5Y CAGR+2.3pp
10Y CAGR+0.6pp

Cencora Inc.'s net profit margin was 0.5% in fiscal year 2025, showing the share of revenue converted to profit. That is unchanged from the prior year.

Return on Equity
103.1%
YoY-130.6pp

Cencora Inc.'s ROE was 103.1% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 130.6 percentage points from the prior year.

Capital Allocation

Share Buybacks
$435.5M
YoY-70.8%
5Y CAGR+0.7%
10Y CAGR-13.5%

Cencora Inc. spent $435.5M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 70.8% from the prior year.

Capital Expenditures
$668.0M
YoY+37.1%
5Y CAGR+12.6%
10Y CAGR+11.2%

Cencora Inc. invested $668.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 37.1% from the prior year.

R&D Spending

Not reported for fiscal year 2025.

COR Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

COR annual income statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Revenue$332.8B$321.3B+9.3%$294.0B+12.1%$262.2B+9.9%$238.6B+11.5%$214.0B+12.7%$189.9B+5.7%$179.6B+6.9%$167.9B+9.7%$153.1B+4.3%$146.8B+8.0%$136.0B+13.7%$119.6B+35.9%$88.0B+12.7%$78.1B-0.8%$78.7B
Cost of Revenue$319.6B$309.9B+9.1%$284.0B+12.2%$253.2B+10.0%$230.3B+11.2%$207.0B+12.1%$184.7B+5.9%$174.5B+6.8%$163.3B+9.9%$148.6B+4.2%$142.6B+7.7%$132.4B+13.6%$116.6B+36.4%$85.5B+13.3%$75.4B-1.0%$76.2B
Gross Profit$13.2B$11.5B+15.8%$9.9B+10.6%$9.0B+8.0%$8.3B+19.5%$6.9B+33.7%$5.2B+1.0%$5.1B+11.4%$4.6B+1.5%$4.5B+6.4%$4.3B+21.1%$3.5B+18.3%$3.0B+18.9%$2.5B-4.8%$2.6B+7.1%$2.5B
SG&A Expenses$7.7B$6.5B+14.7%$5.7B+6.6%$5.3B+9.5%$4.8B+34.9%$3.6B+29.9%$2.8B+3.9%$2.7B+8.3%$2.5B+15.6%$2.1B+1.8%$2.1B+9.6%$1.9B+20.7%$1.6B+18.5%$1.3B+15.7%$1.2B+1.3%$1.1B
Operating Income$3.0B$2.6B+20.8%$2.2B-7.1%$2.3B-1.1%$2.4B+0.5%$2.4B+145.8%-$5.1B-561.8%$1.1B-23.0%$1.4B+36.2%$1.1B-30.5%$1.5B+261.4%$422.2M-46.0%$782.1M-12.9%$898.4M-31.1%$1.3B+9.6%$1.2B
Interest ExpenseN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-$76.9M-4.0%-$73.9M+20.2%-$92.6M-21.6%-$76.1M
Income Tax$967.3M$690.5M+42.5%$484.7M+13.2%$428.3M-17.1%$516.5M-23.7%$677.3M+135.8%-$1.9B-1776.8%$113.0M+125.8%-$438.5M-179.2%$553.4M+1594.9%-$37.0M-109.1%$407.1M+4.9%$388.1M+17.2%$331.0M-27.3%$455.5M+8.3%$420.5M
Net Income$2.6B$1.6B+3.0%$1.5B-13.5%$1.7B+2.7%$1.7B+10.3%$1.5B+145.2%-$3.4B-498.5%$855.4M-48.4%$1.7B+355.0%$364.5M-74.5%$1.4B+1133.5%-$138.2M-150.4%$274.2M-36.8%$433.7M-39.7%$719.0M+1.7%$706.6M
EPS (Diluted)$7.96+5.7%$7.53-11.7%$8.53+6.1%$8.04+8.8%$7.39+144.4%-$16.65-512.1%$4.04-46.3%$7.53+359.1%$1.64-74.1%$6.32+1103.2%-$0.63-154.3%$1.16-37.0%$1.84-34.3%$2.80+10.2%$2.54

Not reported in any period shown, so not listed: R&D Expenses.

TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

COR Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

COR annual balance sheet
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Total Assets$76.6B+14.1%$67.1B+7.3%$62.6B+10.6%$56.6B-1.4%$57.3B+29.5%$44.3B+13.0%$39.2B+4.0%$37.7B+6.7%$35.3B+5.0%$33.6B+20.3%$28.0B+29.9%$21.5B+13.8%$18.9B+22.5%$15.4B+3.1%$15.0B
Current Assets$52.2B+9.5%$47.7B+11.5%$42.8B+8.1%$39.6B+2.0%$38.8B+17.4%$33.1B+17.5%$28.1B+8.6%$25.9B+6.5%$24.3B+6.4%$22.9B+12.4%$20.3B+21.0%$16.8B+16.7%$14.4B+30.2%$11.1B-3.1%$11.4B
Cash & Equivalents$4.4B+39.1%$3.1B+20.9%$2.6B-23.5%$3.4B+33.0%$2.5B-44.6%$4.6B+36.3%$3.4B+35.4%$2.5B+2.4%$2.4B-11.2%$2.7B+26.5%$2.2B+19.8%$1.8B+46.9%$1.2B+15.4%$1.1B-41.6%$1.8B
Inventory$20.5B+7.9%$19.0B+8.8%$17.5B+12.2%$15.6B+1.2%$15.4B+22.1%$12.6B+13.8%$11.1B-7.2%$11.9B+4.0%$11.5B+6.9%$10.7B+9.9%$9.8B+13.5%$8.6B+23.1%$7.0B+27.6%$5.5B+2.9%$5.3B
Accounts Receivable$25.2B+5.7%$23.9B+14.2%$20.9B+13.3%$18.5B+1.6%$18.2B+31.2%$13.8B+11.8%$12.4B+9.5%$11.3B+9.8%$10.3B+12.3%$9.2B+11.6%$8.2B+30.3%$6.3B+4.3%$6.1B+59.9%$3.8B+3.0%$3.7B
Goodwill$13.7B+46.8%$9.3B-2.7%$9.6B+12.6%$8.5B-5.8%$9.0B+34.6%$6.7B0.0%$6.7B+0.6%$6.7B+10.3%$6.0B+0.9%$6.0B+44.6%$4.1B+40.6%$2.9B+0.1%$2.9B+0.1%$2.9B+17.9%$2.5B
Total Liabilities$75.1B+13.0%$66.5B+7.1%$62.0B+9.3%$56.8B-0.6%$57.1B+26.1%$45.3B+24.8%$36.3B+4.5%$34.7B+4.5%$33.3B+5.5%$31.5B+15.2%$27.3B+39.6%$19.6B+17.9%$16.6B+27.9%$13.0B+7.2%$12.1B
Current Liabilities$57.8B+6.5%$54.3B+11.2%$48.8B+12.3%$43.5B+5.1%$41.4B+22.2%$33.9B+14.4%$29.6B+6.1%$27.9B+3.9%$26.8B+6.1%$25.3B+17.2%$21.6B+25.1%$17.3B+16.0%$14.9B+32.0%$11.3B+3.4%$10.9B
Long-Term Debt$7.5B+97.9%$3.8B-8.1%$4.1B-10.5%$4.6B-27.4%$6.4B+76.4%$3.6B-10.3%$4.0B-3.0%$4.2B+21.2%$3.4B-4.1%$3.6B+2.4%$3.5B+75.0%$2.0B+42.9%$1.4B0.0%$1.4B+46.8%$951.0M
Total Equity$1.5B+133.5%$645.9M+23.7%$522.0M+346.7%-$211.6M-194.7%$223.4M+121.9%-$1.0B-135.4%$2.9B-1.8%$2.9B+42.1%$2.1B-3.0%$2.1B+245.5%$616.4M-68.3%$1.9B-15.8%$2.3B-6.0%$2.5B-14.4%$2.9B
Retained Earnings$6.5B+20.6%$5.4B+25.3%$4.3B+45.2%$3.0B+78.2%$1.7B+222.3%$518.3M-87.8%$4.2B+13.8%$3.7B+55.3%$2.4B+4.0%$2.3B+97.8%$1.2B-25.8%$1.6B+4.1%$1.5B+18.7%$1.3B-68.7%$4.1B

COR Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

COR annual cash flow statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Operating Cash Flow$4.8B$3.9B+11.2%$3.5B-10.9%$3.9B+44.7%$2.7B+1.4%$2.7B+20.8%$2.2B-5.8%$2.3B+66.1%$1.4B-6.2%$1.5B-52.7%$3.2B-19.0%$3.9B+167.8%$1.5B+85.8%$788.1M-39.6%$1.3B+11.8%$1.2B
Capital Expenditures$760.8M$668.0M+37.1%$487.2M+6.3%$458.4M-7.6%$496.3M+13.3%$438.2M+18.5%$369.7M+19.2%$310.2M-7.8%$336.4M-27.9%$466.4M+0.4%$464.6M+100.6%$231.6M-12.4%$264.5M+30.6%$202.4M+51.9%$133.3M-14.6%$156.1M
Free Cash Flow$4.1B$3.2B+7.0%$3.0B-13.2%$3.5B+56.5%$2.2B-1.0%$2.2B+21.3%$1.8B-9.7%$2.0B+89.2%$1.1B+3.6%$1.0B-61.8%$2.7B-26.5%$3.7B+207.5%$1.2B+104.9%$585.7M-50.0%$1.2B+15.8%$1.0B
Investing Cash Flow-$5.7B-$5.0B-705.3%-$618.1M+76.2%-$2.6B-606.4%-$368.4M+94.0%-$6.1B-1516.8%-$379.9M-1.1%-$375.8M+66.2%-$1.1B-123.1%-$498.0M+84.3%-$3.2B-8.1%-$2.9B-663.0%-$384.2M-427.6%$117.3M+112.4%-$947.9M-346.3%-$212.4M
Financing Cash Flow$1.6B$2.2B+196.5%-$2.3B-4.9%-$2.2B-26.8%-$1.8B-189.8%$2.0B+423.5%-$603.6M+44.4%-$1.1B-347.4%-$242.9M+81.5%-$1.3B-332.3%$565.1M+189.4%-$632.1M-25.7%-$503.0M+32.1%-$741.0M+33.7%-$1.1B-41.8%-$787.7M
Dividends Paid$468.1M$437.1M+5.0%$416.2M+4.4%$398.8M+1.8%$391.7M+6.8%$366.6M+6.7%$343.6M+1.4%$339.0M+1.8%$333.0M+4.0%$320.3M+11.0%$288.5M+13.6%$253.9M+18.4%$214.5M+9.6%$195.7M+47.4%$132.8M+12.9%$117.6M
Share Buybacks$1.0B$435.5M-70.8%$1.5B+26.3%$1.2B+144.1%$483.7M+488.8%$82.2M-80.5%$420.4M-37.6%$674.0M+5.4%$639.2M+93.7%$329.9M-85.4%$2.3B+21.9%$1.9B+146.6%$753.9M+55.7%$484.2M-58.3%$1.2B+38.3%$840.6M

TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

COR Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

COR annual financial ratios
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Gross Margin3.6%+0.2pp3.4%-0.1pp3.4%-0.1pp3.5%+0.2pp3.2%+0.5pp2.7%-0.1pp2.9%+0.1pp2.8%-0.2pp3.0%+0.1pp2.9%+0.3pp2.6%+0.1pp2.5%-0.4pp2.9%-0.5pp3.4%+0.3pp3.1%
Operating Margin0.8%+0.1pp0.7%-0.1pp0.9%-0.1pp1.0%-0.1pp1.1%+3.8pp-2.7%-3.3pp0.6%-0.2pp0.9%+0.2pp0.7%-0.3pp1.0%+0.7pp0.3%-0.3pp0.7%-0.4pp1.0%-0.6pp1.7%+0.2pp1.5%
Net Margin0.5%0.0pp0.5%-0.2pp0.7%0.0pp0.7%0.0pp0.7%+2.5pp-1.8%-2.3pp0.5%-0.5pp1.0%+0.8pp0.2%-0.7pp1.0%+1.1pp-0.1%-0.3pp0.2%-0.3pp0.5%-0.4pp0.9%0.0pp0.9%
Return on Equity103.1%-130.6pp233.6%-100.7pp334.4%N/A689.5%N/A29.7%-26.8pp56.5%+38.9pp17.7%-49.4pp67.1%+89.5pp-22.4%-36.5pp14.1%-4.7pp18.8%-10.5pp29.3%+4.6pp24.6%
Return on Assets2.0%-0.2pp2.3%-0.5pp2.8%-0.2pp3.0%+0.3pp2.7%+10.4pp-7.7%-9.9pp2.2%-2.2pp4.4%+3.4pp1.0%-3.2pp4.3%+4.7pp-0.5%-1.8pp1.3%-1.0pp2.3%-2.4pp4.7%-0.1pp4.7%
Current Ratio0.900.0x0.880.0x0.880.0x0.910.0x0.940.0x0.980.0x0.950.0x0.930.0x0.910.0x0.900.0x0.940.0x0.970.0x0.970.0x0.98-0.1x1.05
Debt-to-Equity5.00-0.9x5.90-2.0x7.94N/A28.58N/A1.400.0x1.42-0.2x1.660.0x1.68-4.0x5.67+4.6x1.03+0.4x0.610.0x0.57+0.2x0.33
FCF Margin1.0%0.0pp1.0%-0.3pp1.3%+0.4pp0.9%-0.1pp1.0%+0.1pp1.0%-0.2pp1.1%+0.5pp0.6%0.0pp0.7%-1.2pp1.8%-0.9pp2.7%+1.7pp1.0%+0.3pp0.7%-0.8pp1.5%+0.2pp1.3%

Note: The current ratio is below 1.0 (0.90), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Frequently Asked Questions

What is Cencora Inc.'s annual revenue?

Cencora Inc. (COR) reported $321.3B in total revenue for fiscal year 2025. This represents a 9.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Cencora Inc.'s revenue growing?

Cencora Inc. (COR) revenue grew by 9.3% year-over-year, from $294.0B to $321.3B in fiscal year 2025.

Is Cencora Inc. profitable?

Yes, Cencora Inc. (COR) reported a net income of $1.6B in fiscal year 2025, with a net profit margin of 0.5%.

Cencora Inc. (COR) reported diluted earnings per share of $7.96 for fiscal year 2025. This represents a 5.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Cencora Inc. (COR) had EBITDA of $3.7B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Cencora Inc. (COR) had $4.4B in cash and equivalents against $7.5B in long-term debt.

Cencora Inc. (COR) had a gross margin of 3.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Cencora Inc. (COR) had an operating margin of 0.8% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Cencora Inc. (COR) had a net profit margin of 0.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, Cencora Inc. (COR) paid $2.20 per share in dividends during fiscal year 2025.

Cencora Inc. (COR) has a return on equity of 103.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Cencora Inc. (COR) generated $3.2B in free cash flow during fiscal year 2025. This represents a 7.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Cencora Inc. (COR) generated $3.9B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Cencora Inc. (COR) had $76.6B in total assets as of fiscal year 2025, including both current and long-term assets.

Cencora Inc. (COR) invested $668.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, Cencora Inc. (COR) spent $435.5M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Cencora Inc. (COR) had 194M shares outstanding as of fiscal year 2025.

Cencora Inc. (COR) had a current ratio of 0.90 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

Cencora Inc. (COR) had a debt-to-equity ratio of 5.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Cencora Inc. (COR) had a return on assets of 2.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Cencora Inc. (COR) has an Altman Z-Score of 4.83, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Cencora Inc. (COR) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Cencora Inc. (COR) has an earnings quality ratio of 2.49x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Cencora Inc. (COR) scores 51 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top